| abstract |
Phospholipids (e.g. MPPA and DPPS) show a remarkable antimicrobial effect against gram negative (e.g. Pseudomonas and Klebsiella) and gram positive (e.g. Staphylococcus and Enterococcus) bacteria. When the phospholipids are combined with antibiotics (e.g. ampicillin, ceftazidime, or piperacillin) the effect of the antibiotic is enhanced by the presence of the phospholipid. The substance of the invention will be used alone or in combination with antibiotics, antimicrobials, antifungal, antiviral, or antiprotozoal drugs for the combat of infectious diseases, such as prophylactic, cytocidal, antibacterial, bacteriostatic, and/or bacteriocidal effects. |